In-silico and in-vivo evaluation of sesamol and its derivatives for benign prostatic hypertrophy

Pharmacological treatment for BPH includes 5-α reductase inhibitors as Finasteride and Dutasteride as a monotherapy or in combination with antimuscarinic drugs, alpha-blockers, 5-phosphodiesterase inhibitor drugs. Androgen receptor inhibitors revealed several adverse events as decreased libido, erec...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, Abhishek, Shah, Aarti Abhishek, Nandakumar, Krishnadas, Kumar, Avinash, Pai, Aravinda, Lobo, Richard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364611/
https://www.ncbi.nlm.nih.gov/pubmed/34466348
http://dx.doi.org/10.1007/s13205-021-02952-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364611/
https://www.ncbi.nlm.nih.gov/pubmed/34466348
http://dx.doi.org/10.1007/s13205-021-02952-z

Ejemplares similares